Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Journal of Viral Hepatitis|January 30, 2009
Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virusT Poynard, Y Ngo, P Marcellin, et al.Journal of Hepatology|July 4, 2001
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis cT Poynard, V Ratziu, F Charlotte, et al.Bailliere'S Best Practice & Research. Clinical Gastroenterology|July 13, 2000
Natural history of HCV infectionT Poynard, V Ratziu, Y Benhamou, et al.Alimentary Pharmacology & Therapeutics|October 1, 2014
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver diseaseL Fedchuk, F Nascimbeni, R Pais, et al.Journal of Viral Hepatitis|January 13, 2001
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 updateT Thévenot, C Regimbeau, V Ratziu, et al.Seminars in Liver Disease|July 15, 2000
Fibrosis in patients with chronic hepatitis C: detection and significanceT Poynard, V Ratziu, Y Benmanov, et al.Lancet (London, England)|April 12, 2001
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective studyF Imbert-Bismut, V Ratziu, L Pieroni, et al.Alimentary Pharmacology & Therapeutics|January 6, 2006
Blood oxidative stress markers are unreliable markers of hepatic steatosisD Bonnefont-Rousselot, V Ratziu, P Giral, et al.Bulletin Du Cancer|February 20, 2010
[Hepatotoxicity of metastatic colorectal cancer chemotherapy: systematic review]I Baumgaertner, V Ratziu, J-C Vaillant, et al.Alimentary Pharmacology & Therapeutics|September 1, 2017
Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year periodR Pais, L Fartoux, C Goumard, et al.Pageof 5